As per this study the Global CRISPR Technology Market was valued USD 3.86 BN (by revenue) in 2022 and is anticipated to reach USD 13.11 BN by 2030 with a CAGR of 16.5%.
CRISPR is the shorthand for Clustered Regularly Interspaced Short Palindromic Repeats. This CRISPR technology enables a simple and affordable way to manipulate and edit DNA, completely changing the face of genome engineering. It has limitless applications still researchers are working for developing new ways to cure diseases such as cancer, blindness, and Alzheimer's disease. It is also used for producing fuel, manufacturing chemicals and for improving food crops.
Market Dynamics
Growing adoption of CRISPR technology in various applications such as biomedical, agricultural and industrial applications coupled with biological research is again boosting the market growth. Rising investment by government in the field of genetic study for the development of novel drugs will further favor the market growth. On the flip side, off-target activity and the presence of alternative technologies may hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of CRISPR technology.
Market Segmentation
The broad CRISPR technology market has been sub-grouped into products & Services, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product & Services
- Products (CRISPR Kits & Enzymes, CRISPR Libraries, Other Products (Design Tools, Antibodies, Other Reagents))
- Services (gRNA Design & Vector Construction, Cell Line Engineering, Screening Services, Other Services (Epigenome Editing and Transcriptional Activation))
By Application
- Drug Discovery & Development
- Agriculture
- Other Applications (Biofuels, Veterinary)
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others (CROs & CDMOs)
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for CRISPR technology in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
CRISPR Technology Market Size, Share Analysis Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the CRISPR technology market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Genscript Biotech Corporation (China), CRISPR Therapeutics AG (Switzerland), Editas Medicine (US), Intellia Therapeutics Inc. (US), Beam Therapeutics Inc. (US), Carbou Biosciences Inc. (US), Lonza Group, Ltd. (Switzerland), Danaher Corporation (US), PerkinElmer Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.